Proteinuria  >>  CCX140  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CCX140 / Amgen, CSL Behring
NCT01440257 / 2011-003049-16: A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

Completed
2
20
Europe
Placebo, CCX140-B
ChemoCentryx
Diabetic Nephropathy, Type 2 Diabetes Mellitus
02/13
09/13

Download Options